Second Chance for Moms Act
United States119th CongressHR-796House of Representatives
Updated: Jan 28, 2025
Summary
This bill, titled the "Second Chance for Moms Act of 2025," aims to inform women about the potential to counteract the effects of mifepristone. It mandates a conspicuous warning label on mifepristone packaging, advising that medical evidence suggests its abortifacient effects can be counteracted by natural progesterone, which may increase the chance of fetal survival. The label would also note the American Society for Reproductive Medicine's determination that natural progesterone is safe in the first trimester. Furthermore, the legislation establishes a toll-free hotline , operating 24/7, to provide support and information to women seeking to reverse mifepristone's effects. This hotline would exclusively refer callers to healthcare providers specializing in abortion pill reversal services.
Bill texts
All available records shown.
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
House of Representatives
All available records shown.